Benzyl Bromide

Benzyl Bromide

SCHEMBL3575272

BrCc1ccccc1.OCCO

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.78
ALDH1A1 P00352 3/20 0.78
TRPA1 O75762 2/20 0.78
TDP1 Q9NUW8 2/20 0.55
CES2 O00748 2/20 0.52
CES1 P23141 2/20 0.52
CALM1 P0DP23 1/20 0.43
IDO1 P14902 2/20 0.40
THRB P10828 1/20 0.40
AKR1B1 P15121 1/20 0.40
HPGD P15428 2/20 0.39
TP53 P04637 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.39
MAOB P27338 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
CASP1 P29466 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzyl Bromide SCHEMBL5964841 0.88
SCHEMBL20389321 0.88 TSHR (1.00) TSHRALDH1A1TRPA1TDP1CES2
Benzyl Bromide SCHEMBL5757393 0.88 TSHR (1.00) TSHRALDH1A1TRPA1TDP1CES2
Benzyl Bromide SCHEMBL1331189 0.88
Benzyl Bromide SCHEMBL9000955 0.88 TSHR (1.00) TSHRALDH1A1TRPA1TDP1CES2
Benzyl Bromide SCHEMBL1066 0.88
Benzyl Bromide SCHEMBL8426405 0.86 TSHR (0.74) TSHRALDH1A1TRPA1TDP1CES2
Benzyl Bromide SCHEMBL28763610 0.86 ALDH1A1 (0.82) TSHRALDH1A1TRPA1TDP1CES2
Benzyl Bromide SCHEMBL905931 0.85
Benzyl Bromide SCHEMBL4313280 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807827-B2 Procedure for preparing 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazineyl)-dibenzo[b,f] [1,4]thiazepine INKE, S.A. (ES) 2010-10-05 US disclosed
EP-1660468-B1 PROCEDURE FOR PREPARING 11-(4-[2-(2-HYDROXYETHOXY)ETHYL]-1-PIPERAZINYL)-DIBENZO[B,F][1,4]THIAZEPINE INKE SA (ES) 2007-07-18 EP disclosed
US-20060189594-A1 Procedure for preparing a pharmaceutically active compound INKE, S.A. (ES) 2006-08-24 US disclosed
EP-1660468-A2 PROCEDURE FOR PREPARING 11-(4-[2-(2-HYDROXYETHOXY)ETHYL]-1-PIPERAZINYL)-DIBENZO[B,F][1,4]THIAZEPINE INKE, S.A. (ES) 2006-05-31 EP disclosed
WO-2005014590-A2 PROCEDURE FOR PREPARING 11-(4`2-(2-HYDROXYETHOXY )ETHYL!-1-PIPERAZINYL!-DIBENZO`B,F!`1,4!THIAZEPINE INKE, S.A. (ES) 2005-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189594-A1 Procedure for preparing a pharmaceutically active compound CYP3A5, CYP2C19, CYP3A7 TSHR 1776/4885ALDH1A1 876/4885TRPA1 3175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.